188 related articles for article (PubMed ID: 32131689)
1. Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction.
Solomon MD; Leong TK; Levin E; Rana JS; Jaffe MG; Sidney S; Sung SH; Lee C; DeMaria A; Go AS
J Am Heart Assoc; 2020 Mar; 9(6):e014415. PubMed ID: 32131689
[TBL] [Abstract][Full Text] [Related]
2. Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.
Ergatoudes C; Thunström E; Rosengren A; Björck L; Bengtsson Boström K; Falk K; Fu M
BMC Cardiovasc Disord; 2016 Nov; 16(1):226. PubMed ID: 27855640
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention after acute myocardial infarction: drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry.
Urbinati S; Olivari Z; Gonzini L; Savonitto S; Farina R; Del Pinto M; Valbusa A; Fantini G; Mazzoni A; Maggioni AP;
Eur J Prev Cardiol; 2015 Dec; 22(12):1548-56. PubMed ID: 25452625
[TBL] [Abstract][Full Text] [Related]
4. Association Between Medication Adherence and 1-Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China.
Shang P; Liu GG; Zheng X; Ho PM; Hu S; Li J; Jiang Z; Li X; Bai X; Gao Y; Xing C; Wang Y; Normand SL; Krumholz HM
J Am Heart Assoc; 2019 May; 8(9):e011793. PubMed ID: 31057004
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
[TBL] [Abstract][Full Text] [Related]
6. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
[TBL] [Abstract][Full Text] [Related]
7. Association Between Secondary Prevention Medication Use and Outcomes in Frail Older Adults After Acute Myocardial Infarction.
Zullo AR; Mogul A; Corsi K; Shah NR; Lee SJ; Rudolph JL; Wu WC; Dapaah-Afriyie R; Berard-Collins C; Steinman MA
Circ Cardiovasc Qual Outcomes; 2019 Apr; 12(4):e004942. PubMed ID: 31002274
[TBL] [Abstract][Full Text] [Related]
8. Tackling inequalities: are secondary prevention therapies for reducing post-infarction mortality used without disparities?
Buja A; Boemo DG; Furlan P; Bertoncello C; Casale P; Baldovin T; Marcolongo A; Baldo V
Eur J Prev Cardiol; 2014 Feb; 21(2):222-30. PubMed ID: 22997352
[TBL] [Abstract][Full Text] [Related]
9. Determinants of suboptimal long-term secondary prevention of acute myocardial infarction: the structural interview method and physical examinations.
Sakalaki M; Barywani S; Rosengren A; Björck L; Fu M
BMC Cardiovasc Disord; 2019 Nov; 19(1):243. PubMed ID: 31694556
[TBL] [Abstract][Full Text] [Related]
10. Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence: Problem for Young Women.
Smolina K; Ball L; Humphries KH; Khan N; Morgan SG
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):586-92. PubMed ID: 26462876
[TBL] [Abstract][Full Text] [Related]
11. Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data.
Kuepper-Nybelen J; Hellmich M; Abbas S; Ihle P; Griebenow R; Schubert I
Eur J Clin Pharmacol; 2012 Oct; 68(10):1451-60. PubMed ID: 22476389
[TBL] [Abstract][Full Text] [Related]
12. Time trends and gender differences in prevention guideline adherence and outcome after myocardial infarction: Data from the SWEDEHEART registry.
Hambraeus K; Tydén P; Lindahl B
Eur J Prev Cardiol; 2016 Mar; 23(4):340-8. PubMed ID: 25986497
[TBL] [Abstract][Full Text] [Related]
13. Association of Patient Enrollment in Medicare Part D With Outcomes After Acute Myocardial Infarction.
Goyal A; de Lemos JA; Peng SA; Thomas L; Amsterdam EA; Hockenberry JM; Peterson ED; Wang TY
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):567-75. PubMed ID: 26508667
[TBL] [Abstract][Full Text] [Related]
14. Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study.
Liosis S; Bauer T; Schiele R; Gohlke H; Gottwik M; Katus H; Sabin G; Zahn R; Schneider S; Rauch B; Senges J; Zeymer U
Clin Res Cardiol; 2013 Sep; 102(9):671-7. PubMed ID: 23740196
[TBL] [Abstract][Full Text] [Related]
15. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
[TBL] [Abstract][Full Text] [Related]
16. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
[TBL] [Abstract][Full Text] [Related]
17. Does age modify the relationship between adherence to secondary prevention medications and mortality after acute myocardial infarction? A nested case-control study.
Lenzi J; Rucci P; Castaldini I; Protonotari A; Di Pasquale G; Di Martino M; Perrone E; Forti P; Fantini MP
Eur J Clin Pharmacol; 2015 Feb; 71(2):243-50. PubMed ID: 25529226
[TBL] [Abstract][Full Text] [Related]
18. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
[TBL] [Abstract][Full Text] [Related]
19. Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.
Neumann A; Maura G; Weill A; Alla F; Danchin N
Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004356. PubMed ID: 29653999
[TBL] [Abstract][Full Text] [Related]
20. Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion.
Ribas N; García-García C; Meroño O; Recasens L; Pérez-Fernández S; Bazán V; Salvatella N; Martí-Almor J; Bruguera J; Elosua R
BMC Cardiovasc Disord; 2017 Feb; 17(1):54. PubMed ID: 28173757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
